News

Discover the All-New Aventon Abound LR Cargo eBike

Discover the All-New Aventon Abound LR Cargo eBike

Introducing the All-New Aventon Abound LR

Aventon, renowned for its innovative electric bicycles, has taken a bold step forward with the launch of the Abound LR cargo eBike. Designed with an improved geometry and a gravity casted frame, this model enhances the riding experience for those needing extra space for cargo.

Key Features of the Abound LR

The Abound LR represents the next generation of Aventon's cargo bikes. With its Class 2 eBike designation, it offers a remarkable range of up to 60 miles, making it perfect for daily errands or long rides. Its features include a fully equipped cockpit with fenders, a front suspension fork, and an adjustable suspension seat post that provides comfort regardless of the load.

Built for Convenience and Safety

What sets the Abound LR apart is its commitment to safety and security. Equipped with a robust 750W, 36V Hub Drive Motor that delivers 80Nm of torque and a peak power of 1188W, this eBike can comfortably handle a maximum payload of 440 lbs. Safety is enhanced with Tektro Hydraulic Disc Brakes, ensuring reliable stopping power in various conditions.

Advanced Connectivity and Security

The Aventon Control Unit (ACU) is a game-changer. With advanced features including Real-time Location Tracking, GPS, Remote Locking, and a unique e-Lock Kickstand, riders can enjoy peace of mind knowing their bike is protected. The ACU also provides real-time performance stats, making every ride more enjoyable and insightful.

Pricing and Availability

The Abound LR is available at a manufacturer's suggested retail price of $1,999. Customers can now order this cutting-edge cargo eBike for immediate shipping, ensuring that they can hit the roads with their new ride in no time.

About Aventon

Founded in Southern California, Aventon has established itself as a leader in the bicycle manufacturing industry. CEO JW Zhang’s vision to create high-quality and affordable bikes has driven Aventon to innovate continuously. The brand has successfully transitioned from traditional bicycles to e-mobility, focusing on both performance and user experience.

Commitment to Adventure

Aventon believes in redefining adventure for every cyclist. Their products are designed to enhance every ride, making it possible for everyone, regardless of their cycling background, to enjoy the thrill of exploring the world by bike. With over 1,800 dealers nationwide, Aventon is committed to customer satisfaction and technological advancement.

Frequently Asked Questions

What is the range of the Aventon Abound LR?

The Abound LR can achieve a remarkable range of up to 60 miles on a single charge, making it ideal for both short trips and long-distance rides.

What is the weight capacity of the Abound LR?

This cargo eBike can accommodate a maximum payload of 440 lbs, making it suitable for transporting various goods.

What features enhance the safety of the Abound LR?

The Abound LR includes Tektro Hydraulic Disc Brakes for superior stopping power, ensuring safe navigation in diverse conditions.

How does the Aventon Control Unit work?

The ACU features real-time tracking, geofencing, and remote lock capabilities, providing enhanced security and connectivity while riding.

Where can I purchase the Aventon Abound LR?

The Abound LR is available for $1,999 and can be ordered directly from Aventon or from any of their dealer locations nationwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading